ResMed News Breakdown |
| RMD -- USA Stock | USD 108.81 0.29 0.27% |
Macroaxis does not monitor all media channels or aggregates social signals for ResMed. But even though we do not provide professional-grade financial sentiment analysis on ResMed, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for ResMed. Additionally take a look at ResMed Hype Analysis, ResMed Correlation and ResMed Performance.
Filed transaction by Resmed Inc officer. General open market or private sale of non-derivative or derivative security | |||||||||
Filed transaction by Resmed Inc officer. General open market or private sale of non-derivative or derivative security | |||||||||
Filed transaction by Resmed Inc officer. General open market or private sale of non-derivative or derivative security | |||||||||
Filed transaction by Resmed Inc director. Unconventional Insider trading | |||||||||
Filed transaction by Resmed Inc officer. General open market or private sale of non-derivative or derivative security | |||||||||
Filed transaction by Resmed Inc officer. Unconventional Insider trading | |||||||||
Filed transaction by Resmed Inc officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | |||||||||
Filed transaction by Resmed Inc director. General open market or private sale of non-derivative or derivative security | |||||||||
Zacks.comStocks in the News Investors Taking a Second Look at ResMed Inc. After Recent Market Moves The Coin Guild Get full coverage | |||||||||
MTL News Get full coverage | |||||||||
Filed transaction by Resmed Inc director. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | |||||||||
News Stays On Track Take note of This Stock ResMed Inc. NYSE WIRED Get full coverage | |||||||||
Filed transaction by Resmed Inc director. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | |||||||||
Analyst Journal Get full coverage | |||||||||
Filed transaction by Resmed Inc officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | |||||||||
Build Optimal Portfolios
Diversify Your Portfolio With ResMed
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add ResMed to your portfolio
Investors are also looking into
| Acquisition or disposition of Freds securities by Moore GailJuly 20, 2018 for Moore Gail | |
| Payment of 236 shares by Gravelle Michael L of Fidelity National subject to Rule 16b 3July 20, 2018 for Gravelle Michael L | |
| Sale by Mckinney Daniel S of 500 shares of Sino BioenergyJuly 19, 2018 for Mckinney Daniel S |
| View All Premium Stories |
Performance against DOW
Price Growth (%) |
1 | What Kind of Picture Are the Technicals Painting For ResMed ... | 06/29/2018 |
2 | Is The Needle Ready to Move For ResMed Inc Shares tick 0.18 | 07/10/2018 |
3 | Exercise or conversion by Rob Douglas of 7500 shares of ResM... | 07/13/2018 |
4 | ResMed exotic insider transaction detected | 07/16/2018 |
5 | Sale by Michael Farrell of 3200 shares of ResMed | 07/19/2018 |
Additionally take a look at ResMed Hype Analysis, ResMed Correlation and ResMed Performance. Please also try Cryptocurrency Arbitrage module to find pairs of digital assets on multiple exchanges that are traded at a risk free arbitrage.